As a pharmaceutical injury attorney, I already knew that Type II diabetes drug Byetta (exenatide) had serious safety problems. In fact, when it was approved as a stand-alone treatment for…
Read More
As a pharmaceutical liability attorney, I have noticed several reports of serious safety problems with the newest drugs intended for treatment of Type II diabetes. So I was disappointed, but…
Read More
According to a new study published in the British Journal of Sports Medicine, anabolic steroids and reduced mental health later on in life are linked. This study was conducted with…
Read More
As a defective drug lawyer, I keep a close watch on news related to prescription antidepressants because so many have had safety issues. That’s why I was very interested in…
Read More
I’ve written here many times about the ways injured people are seeking compensation from generic drug companies after PLIVA v. Mensing. In that case, the U.S. Supreme Court ruled that…
Read More
Barr Laboratories is recalling one lot of its generic Adderall due to a serious manufacturing defect, the Los Angeles Times reported Aug. 14. The laboratory is recalling lot number 311756…
Read More
The U.S. Food and Drug Administration has required the strongest warning label a drug can have for two painkillers, the Washington Post reported July 8. Darvon (propoxyphene) and Darvocet (propoxyphene…
Read More
Injuries from defective drugs don’t just take place in the United States. As a pharmaceutical liability attorney, I handle claims from across the U.S.—but most of these highly profitable “blockbuster”…
Read More
Researchers who study the effectiveness and safety of asthma drugs are questioning the results of a new study, Reuters reported Aug. 19. The new study examines the safety of a…
Read More
According to the results of a first-time study that was published in the Journal of Adolescent Health, smoking and depression during teen years negatively impact the bone’s mineral density. This…
Read More